Company page

Diamedica Therapeutics Inc.

Diamedica Therapeutics Inc. (Ticker: DMAC) is a public company based in America with a market capitalization of approximately $362.9 million. The company focuses on developing innovative therapies for neurological diseases. Its commitment to advancing healthcare solutions positions it as a notable player in the biotechnology sector.